|
10 Oct 2020 |
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors
|
|
10 Oct 2020 |
PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint
|
|
10 Oct 2020 |
Sobi announces topline phase 3 data of avatrombopag for the treatment of Chemotherapy-Induced Thrombocytopenia
|
|
10 Oct 2020 |
COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials
|
|
09 Oct 2020 |
Exelixis to Present the Preclinical Profile and Initial Clinical Pharmacokinetics of XL092, Its Next-Generation Oral Tyrosine Kinase Inhibitor
|
|
09 Oct 2020 |
Exelixis and Aurigene Announce That Promising Preclinical Data to Be Presented at the ENA Symposium Support the Clinical Development of a Novel CDK7 Inhibitor
|
|
09 Oct 2020 |
Selecta Biosciences and IGAN Biosciences Enter into Research License and Option Agreement to Study Selecta’s ImmTOR™ Immune Tolerance Platform in Combination with IGAN’s IgA Protease for the Treatment of IgA Nephropathy
|
|
09 Oct 2020 |
First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine
|
|
09 Oct 2020 |
Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen
|
|
08 Oct 2020 |
Cytovia Therapeutics partners with Inserm to develop selective CD38 NK therapeutics and offer new treatment options for Multiple Myeloma patients
|
|
08 Oct 2020 |
Vincera Pharma, Inc Announces Exclusive License Agreement for Oncology Portfolio Including a Clinical-stage PTEFb/CDK9 Inhibitor and a Preclinical Bioconjugation Platform
|
|
08 Oct 2020 |
Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure
|
|
08 Oct 2020 |
Almirall and the University of Dundee announce a multi-target research collaboration to develop novel Targeted Protein Degraders medicines
|
|
08 Oct 2020 |
TIO Bioventures Launches TCRyption Inc., a Novel TCR-T cell based Immunotherapy Company
|
|
08 Oct 2020 |
Ocular Therapeutix™ Announces Topline Phase 1 Clinical Trial Results of OTX-CSI
|
|
08 Oct 2020 |
Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
|
|
08 Oct 2020 |
Moderna Announces Updates on Respiratory Syncytial Virus (RSV) Vaccine Program
|
|
08 Oct 2020 |
IMV Provides Updates On COVID-19 Vaccine Program
|
|
08 Oct 2020 |
Treatment With Islatravir and Doravirine Maintained Viral Suppression and No Viral Resistance was Identified
|
|
08 Oct 2020 |
Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
|
